Ocrelizumab‐induced colitis: VigiBase disproportionality analysis, case reports and literature review
Together, our findings of two relevant clinical cases of ocrelizumab-induced colitis, the literature review and the significant VigiBase disproportionality, suggest a potential safety signal for ocrelizumab.
Authors
- Audrey Fresse (ORCID: https://orcid.org/0000-0001-7876-9846)
- Christophe Hommel
- Nadine Petitpain (ORCID: https://orcid.org/0000-0003-0225-3178)
- Philippe Kerschen
Institutions
- Centre Hospitalier de Luxembourg (LU)
- Centre Hospitalier Régional et Universitaire de Nancy (FR)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2026-02-15
- DOI
- https://doi.org/10.1002/bcp.70490
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00